BBIO — Bridgebio Pharma Inc
In 2026 Q2, 6 of the 140 tracked hedge funds reported a position in Bridgebio Pharma Inc (BBIO), worth $1.21B combined. Over the quarter 3 opened or added, 4 trimmed or exited.
Hedge fund holders, 2026 Q2
| Fund | Value | Portfolio % | Change |
|---|---|---|---|
| Kohlberg | $988.33M | 17.31% | NEW |
| Polar Capital | $153.70M | 0.44% | -18.1% |
| Renaissance | $63.82M | 0.09% | +134.3% |
| Quadrature | $1.94M | 0.02% | NEW |
| Emerald Mutual | $1.40M | 0.05% | -94.1% |
| Persistent | $140.45K | 0.04% | -97.8% |
All stocks · Quarterly Trends · Hedge Fund Tracker
Source: SEC EDGAR 13F filings, reported as of quarter end and filed up to 45 days later. Not investment advice.